Objective: The aim of this study was to investigate the role of dietary micronutrient intake in systemic lupus erythematosus (SLE). Methods: This study included 111 SLE patients and 118 age and gender-matched controls. Data on diet (food frequency questionnaires) were linked with data on Systemic Lupus Activity Measure, Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and carotid atherosclerotic/echolucent plaque (B-mode ultrasound). Dietary micronutrient intake were compared between SLE patients and controls and in relation to lupus activity and atherosclerosis in SLE. Associations between micronutrient intake and plaque were analyzed through logistic regression, adjusted for potential confounders. Results: Micronutrient intake did not differ between patients and controls, and between lower and higher lupus activity, apart from the fact that phosphorus was associated with SLEDAI > 6. In SLE patients, some micronutrients were associated with atherosclerotic plaque, left side. Lower intake of riboflavin and phosphorus was associated with atherosclerotic plaque, left side (odds ratio (OR) 3.06, 95% confidence interval (CI) 1. respectively). Higher intake of selenium and thiamin was inversely associated with atherosclerotic plaque, left side (OR 0.28, 95% CI 0.09-0.89 and OR 0.26, 95% CI 0.08-0.80, respectively). In addition, higher intake of thiamin was inversely associated with echolucent plaque, left side (OR 0.22, 95% CI 0.06-0.84). Lower intake of folate was inversely associated with bilateral echolucent plaque (OR 0.36, 95% CI 0.13-0.99). Conclusions: SLE patients did not have different dietary micronutrient intake compared to controls. Phosphorus was associated with lupus activity. Riboflavin, phosphorus, selenium and thiamin were inversely associated with atherosclerotic plaque, left side in SLE patients, but not in controls. Dietary micronutrients may play a role in atherosclerosis in SLE. Lupus (2016) 25, 1602-1609.
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disease with unknown cause that occurs primarily in women and can involve any organ. SLE patients often present with general systemic inflammation with specific physical manifestations involving the heart, joints, skin, lungs, blood vessels, liver, kidneys and nervous system. 1, 2 The prevalence of carotid atherosclerotic plaques and the risk of developing cardiovascular disease (CVD) are increased in patients with SLE compared to healthy controls. [3] [4] [5] [6] [7] [8] A combination of traditional and non-traditional risk factors contribute to this high risk and CVD in SLE and is associated with an increased prevalence of atherosclerosis. 8 During recent years, it has become clear that atherosclerosis and its main complication, CVD, is an inflammatory condition in which the immune system potentially could influence the disease development. 9 The high risk of CVD in SLE is therefore interesting as it could shed light on immune mechanisms in human atherosclerosis, in addition to being an important clinical problem for many SLE patients.
Ultrasound is a well used instrument for detecting atherosclerotic plaque as well as measuring the carotid artery intimamedia thickness (IMT). 10 IMT is preferably measured in the common carotid artery because it is easier to visualize and it is a reproducible method. 11, 12 In addition, measurement of the internal carotid artery has also been a successful method of detecting and measuring carotid plaque in patients with atherosclerosis and/or other cardiovascular-related conditions. 13, 14 We recently reported that the prevalence of atherosclerotic plaque is increased in this study group. Furthermore, echolucent plaques, which have been associated with vulnerability, were also raised among SLE patients. 15 IMT has been found to be increased in the left side of the common carotid artery compared to the right side. 16 Relatively little is known about dietary habits in SLE patients. Patients with SLE might have a weakened nutritional status than the general population due to the disease condition as well as the treatment(s). Lower serum levels of zinc and selenium have been found in SLE patients compared to healthy controls. 17 A study on nutritional status and food intake in 170 women with SLE showed an inadequate calcium intake and low consumption of fruits and vegetables in the majority of patients. 18 A higher intake of vitamin B6 and dietary fibre may prevent the occurrence of active disease in Japanese SLE patients. 19 Several studies have shown that fish oil (omega-3 fatty acids) has an anti-inflammatory effect and some studies have even shown its beneficial effect for SLE patients. 20 Furthermore, the Mediterranean diet delays the progression of internal carotid IMT and plaque height in women (aged 60-80 years) and men (aged 55-80 years) with high risk of cardiovascular events. 21 Elkan et al. have studied the macronutrient intake in SLE patients and healthy controls from the Systemic Lupus Erythematosus Vascular Impact Cohort (SLEVIC). The SLE patients had a decreased intake of polyunsaturated fatty acids (including omega-3 and omega-6 fatty acids) and fibre as well as an increased intake of carbohydrates compared to controls. 22 We hypothesized that even micronutrient (vitamin and mineral) intake may differ between these SLE patients and controls and that micronutrients may associate with lupus activity and atherosclerosis in SLE patients.
The aim of this study was to investigate dietary micronutrient intake in SLE patients compared to controls, with focus on disease activity and atherosclerotic measures.
Methods

Study participants
This study was based on data from SLEVIC, 15 This study was approved by the regional ethical review board at Karolinska Institutet, Stockholm, Sweden.
Dietary and laboratory assessment
Patients and controls were asked to complete semiquantitative food frequency questionnaires (FFQs). This self-reported FFQ involved the frequency of intake of 88 food items and beverages during the previous year from inclusion. 23 Completed FFQs were evaluated and an estimation of the daily mean intake of 49 nutrients was calculated (mg/day, mg/day). The nutrient calculations were carried out using nutrient composition values from the Swedish National Food Administration data. 24 The intake of nutrients was computed by multiplying the frequency of consumption of each food item by the nutrient content of the specified portions.
Laboratory variables, such as C-reactive protein (CRP), low-density lipoprotein (LDL) and glucose were measured from overnight fasting venous blood samples, taken at inclusion.
Carotid B-mode ultrasonography
Carotid plaque among participants from SLEVIC has previously been reported by Anania et al. 15 and the methodology was as follows.
The right and left carotid arteries were examined with a duplex scanner (Sequoia, Siemens Acuson, Mountain View, CA, USA) using a 6 MHz linear array transducer. The patients were investigated in the supine position. The carotid arteries were carefully examined with regard to wall changes.
Carotid plaque was defined as a localized IMT of greater than 1 mm and at least a 100% increase in thickness compared with adjacent wall segments. Plaque was screened in the common, internal and external carotid arteries. Plaque occurrence was scored as the absence and the presence of plaque. Plaque morphology in terms of echogenicity was assessed in a modified version of the classification proposed by Gray-Weale et al. 25 and graded from 1 to 4 as echolucent (grade 1), predominantly echolucent (grade 2), predominantly echogenic (grade 3) and echogenic (grade 4). Echolucency was defined with the arterial lumen as reference and echogenicity with the far wall adventitia as reference.
This study compared patients with and without atherosclerotic plaque (grade 1-4) on one or both sides and patients with and without echolucent plaque (grade 1) on one or both sides.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics 22. Data on dietary micronutrient intake were linked with data on SLAM, SLEVIC and plaques. Daily mean intakes of 22 dietary micronutrients were compared between SLE patients and controls. Independent samples t-tests were performed for normally distributed variables and the Mann-Whitney U test for skewed variables (skewness AE 1.00). Micronutrient variables were divided into tertiles based on the total intake from both SLE patients and controls, in which lower intake referred to the 1st tertile or less and higher intake to greater than the 3rd tertile. Lower and moderate/ higher lupus activity was distinguished through cutoff levels at 6 for both SLAM and SLEDAI; low SLAM, SLEDAI 6, moderate/high SLAM, SLEDAI > 6. 26 Associations between daily dietary micronutrient intake and (a) SLE, (b) lupus activity, and (c) bilateral and unilateral atherosclerotic (including echolucent) plaque were analyzed through binary logistic regression and were adjusted for potential confounders when these were significantly associated with the ultrasound determination in a univariate analysis. For atherosclerotic plaque, analyses were adjusted for age, LDL, glucose and hypertension and for echolucent plaque, analyses were adjusted for age and LDL.
Results
Characteristics of the study participants
One hundred and eleven SLE patients, with median disease duration of 9 years, and 118 controls completed the FFQs. All characteristics of these study participants are presented in Table 1 . Fifty-three (47.7%) patients had SLAM > 6 and 23 (20.7%) patients had SLEDAI > 6. Atherosclerotic and echolucent plaque on the left side were more common in SLE patients than controls (P ¼ 0.008 and 0.006, respectively) which is a novel finding. Otherwise, similar data on the whole original SLEVIC population have been presented previously. 27 
Micronutrient intake
Daily micronutrient mean intake did not differ significantly between patients and controls ( Table 2) , and between SLE patients with lower (SLAM, SLEDAI 6) and higher (SLAM, SLEDAI > 6) disease activity. However, a higher intake of phosphorus ( > 2497.35 mg/day) was associated with SLEDAI > 6, after adjusting for age and LDL (odds ratio (OR) 2.82, 95% confidence interval (CI) 1.06-7.52).
In SLE patients, some micronutrients were found to associate with the presence of (Table 3 ). In addition, a higher intake of thiamin had decreased odds of echolucent plaque on the left side, after adjusting for age and LDL (OR 0.22, 95% CI 0.06-0.84). Moreover, patients without any atherosclerotic plaque on the left side had a significantly higher daily intake of several micronutrients compared to patients with atherosclerotic plaque on left side (Table 4) .
No micronutrients were significantly associated with atherosclerotic plaque and echolucent plaque on the right side. However, patients with a lower intake of folate ( 255.21 mg/day) had decreased odds of bilateral echolucent plaque (OR 0.36, 95% CI 0.13-0.99).
In controls, those who had a higher intake of beta-carotene (>4921.21 mg/day) and niacin equivalent (>37.58 mg/day) had decreased odds of atherosclerotic plaque on the right side, after adjusting for age and LDL (OR 0.33, 95% CI 0.11-0.96 and OR 0.23, 95% CI 0.07-077, respectively), but not on the left side. No associations were found between micronutrient intake and bilateral atherosclerotic and echolucent plaque, after adjusting for potential confounders.
Discussion
Little is known from previous studies about the role of micronutrients in SLE. Our study focused on micronutrient intake and atherosclerosis in SLE patients. Micronutrient mean intake did not differ between SLE patients and controls, or between patients with lower and higher lupus activity, apart from the fact that a higher intake of phosphorus was associated with SLEDAI > 6. No associations were found between micronutrient intakes and bilateral atherosclerotic and echolucent plaque. It has previously been reported that IMT in the left side of the common carotid artery is increased compared to the right side. 16 One possible explanation to the thicker intima-media complex on the left side is a more rapid development of atherosclerosis on this side secondary to the difference in gross anatomy of the left and right side. The fact that the left common carotid artery originates directly from the aortic arch may create other shear stress conditions on the left compared to the right side. Shear stress has been shown to be related to IMT. 28 In one study of the relation between atherosclerotic wall changes in the carotid arteries and coronary artery disease, it was found that the left-sided calculated intima-media area, but not the right-sided, correlated significantly with the coronary angiographic score. 29 This seems to indicate a parallel development of atherosclerosis in the left carotid artery and the coronary arteries. A novel observation in this study is that atherosclerotic plaques were more common on the left side in SLE patients as compared to controls. We found that the dietary intake of riboflavin, phosphorus, selenium and thiamin were associated with atherosclerotic/echolucent plaque on the left side. In addition, patients without any atherosclerotic plaque on the left side had also a significantly higher intake of several micronutrients compared to patients with atherosclerotic plaque on the left side A lower intake of riboflavin was associated with atherosclerotic plaque on the left side. One of the first studies on the association between riboflavin and atherosclerosis was published in 1968 by Borets. 30 The author studied the influence of riboflavin in three groups and found that: (a) riboflavin does not influence the coagulation in atherosclerotic patients; (b) riboflavin accelerates the coagulation in patients with atherosclerosis and hypertension; and (c) the simultaneous intake of riboflavin and anticoagulants is beneficial for patients with atherosclerosis and hypertension. 30 A lower intake of phosphorus was associated with atherosclerotic plaque on the left side. Contradictory results have been published regarding the impact of dietary phosphorus on blood pressure and CVD. Some studies claim that dietary phosphorus intake affects serum levels of phosphorus, 31, 32 and some do not. 33, 34 Many studies agree with the fact that an excessive intake of dietary phosphorus from mostly processed food as well as elevated serum levels of phosphorus are associated with a higher risk of CVD. [35] [36] [37] However, a higher intake of phosphorus has been associated with lower blood pressure and decreased risk of hypertension. 38, 39 A higher phosphorus intake obtained from low fat dairy products in particular has shown to decrease the blood pressure. [40] [41] [42] [43] [44] A higher intake of selenium was inversely associated with atherosclerotic plaque on the left side. Selenium has anti-oxidant properties. 45 Serum levels of selenium in SLE patients have been reported to be lower compared to healthy controls. 17, 46 A high selenium lentil diet has been shown to protect against arsenic-induced atherosclerosis in a mouse model. 47 Increased selenium through diet or supplementation may be beneficial for SLE patients.
A higher intake of thiamin was inversely associated with atherosclerotic and echolucent plaque on the left side. Increased intake or supplementation of thiamin may delay the atherosclerotic complications of type 2 diabetes. 48 Thiamin levels in SLE patients have not been well studied. However, patients with SLE and diabetes type 2 both have a higher risk of CVD than the general population, and therefore thiamin intake may be beneficial for SLE patients. Echolucent plaque has been associated with vulnerability; 49 our finding on the association between thiamin and echolucent plaque is of importance because thiamin may associate with echolucent plaque formation in SLE patients. Surprisingly, we saw that folate was associated with bilateral echolucent plaque, although several studies suggest that folate intake (including folic acid supplementation and fortification) has an important role in improving cardiovascular health. 50 Folate deficiency has been associated with increased carotid IMT, which is a marker of atherosclerosis and vascular disease. 51 However, folic acid supplementation has not shown any influence on the coagulation, inflammatory and lipid parameters in patients with atherosclerosis risk factors. 52 The association between dietary folate and carotid plaque, specifically in SLE, remains unclear.
These presented associations were typically found in SLE patients but not in controls; this indicates that these particular micronutrients may be specifically important in SLE.
Limitations
This cross-sectional study included SLE patients with various disease durations. Therefore we cannot rule out that the presence of carotid plaque may not have been related to patients' dietary habits during the previous years from inclusion. The reliability of dietary intake according to the FFQ was verified by the significant correlation reported earlier between the polyunsaturated fatty acids ingested, according to the FFQ, and those found in the subcutaneous fat. Some micronutrients, when consumed together, interfere with each other in physiological environments to a certain extent; however, interactions between nutrients as well as nutrient bioavailability were not taken into account. Some micronutrient intake were below the recommended daily intake. However, dietary supplementation was not taken into account, although nutrient intake from supplements may have covered generously the recommended intake. Specific clinical manifestations and treatment history were not considered in this study.
Conclusions
Our results did not find differences in dietary micronutrient intake between SLE patients and controls, and between patients with lower and higher disease activity apart from the fact that a higher intake of phosphorus was associated with SLEDAI > 6. We found that riboflavin, phosphorus, selenium and thiamin were associated with atherosclerotic/echolucent plaque in SLE patients. In addition, patients without any atherosclerotic plaque on the left side had a significantly higher intake of several micronutrients compared to patients with atherosclerotic plaque on the left side. These associations were not found in controls. Our results suggest that certain dietary micronutrients may play a role in atherosclerosis in SLE.
